The proposed partnership between Charles Drew University (CDU) and UCLA Jonsson Cancer Center seeks to """"""""Eliminate Cancer Health Disparities in Minority and Underserved Populations"""""""". This objective will continue to strengthen the CDU cancer research and training infrastructure by enhancing the participation of minority students, fellows and faculty engaged in Cancer Research, Training, and Cancer Outreach. The partnership will continue to recruit new faculty with career focus in cancer research, education or outreach. Likewise, UCLA and the investigators in the JCCC will have the important opportunity to address, issues related to the unequal burden of cancer in minority populations. The partnership developed during our U56 funding has made a significant impact on our ability to develop strong pilots and partnership programs. A key new and important addition to our U54 program is the development of strong Cancer Outreach Program and Projects. Thereby, we will train more minority investigators addressing issues in cancer research, education, training and outcome in our communities. In view of the rapidly changing demographics of Los Angeles and the state of California, the CDU-UCLA Partnership is ideally situated and will have an opportunity to have a positive impact on reducing cancer incidence and improving survival in minority and underserved populations. The overarching goals of the CDU-UCLA Cancer Partnership Program are to significantly increase the number of minority scientists in cancer research and to enhance the cancer outreach programs at CDU to address significant disparities in cancer among minority populations. Supported and implemented by an Administrative Core, Planning and Evaluation Core, and Developmental Core, the basic program components are 1) research projects;2) the mentoring of students and junior investigators;3) the training seminar series;4) enhance CDU's integrated clinical and tissue biorepository data base on minority suubjects;5) enhance community participation;6) improve our clinical trials resource;and 7) increase faculty recruitment. We plan to submit 2 full projects and 2 pilot projects.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
3U54CA143931-05S1
Application #
8720904
Study Section
Special Emphasis Panel (ZCA1-SRLB-D (O2))
Program Officer
Moten, Carmen P
Project Start
2009-09-29
Project End
2014-08-31
Budget Start
2013-09-01
Budget End
2014-08-31
Support Year
5
Fiscal Year
2013
Total Cost
$168,223
Indirect Cost
$48,916
Name
Charles R. Drew University of Medicine & Science
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
785877408
City
Los Angeles
State
CA
Country
United States
Zip Code
90059
Chung, Seyung S; Oliva, Bryant; Dwabe, Sami et al. (2016) Combination treatment with flavonoid morin and telomerase inhibitor MST‑312 reduces cancer stem cell traits by targeting STAT3 and telomerase. Int J Oncol 49:487-98
Wu, Yanyuan; Sarkissyan, Marianna; Vadgama, Jaydutt V (2016) Epithelial-Mesenchymal Transition and Breast Cancer. J Clin Med 5:
Maxwell, Annette E; Danao, Leda L; Cayetano, Reggie T et al. (2016) Implementation of an evidence-based intervention to promote colorectal cancer screening in community organizations: a cluster randomized trial. Transl Behav Med 6:295-305
Wang, Piwen; Henning, Susanne M; Magyar, Clara E et al. (2016) Green tea and quercetin sensitize PC-3 xenograft prostate tumors to docetaxel chemotherapy. J Exp Clin Cancer Res 35:73
Sherzai, Dean; Sherzai, Ayesha; Lui, Keith et al. (2016) The Association Between Diabetes and Dementia Among Elderly Individuals: A Nationwide Inpatient Sample Analysis. J Geriatr Psychiatry Neurol 29:120-5
Wang, Piwen; Phan, Tien; Gordon, David et al. (2015) Arctigenin in combination with quercetin synergistically enhances the antiproliferative effect in prostate cancer cells. Mol Nutr Food Res 59:250-61
Wang, Piwen; Henning, Susanne M; Heber, David et al. (2015) Sensitization to docetaxel in prostate cancer cells by green tea and quercetin. J Nutr Biochem 26:408-15
Li, Youqiang; Wu, Yanyuan; Abbatiello, Thomas C et al. (2015) Slug contributes to cancer progression by direct regulation of ERα signaling pathway. Int J Oncol 46:1461-72
Dawes, Aaron J; Hemmelgarn, Marian; Nguyen, David K et al. (2015) Are primary care providers prepared to care for survivors of breast cancer in the safety net? Cancer 121:1249-56
Maxwell, Annette E; Young, Sandra; Rabelo Vega, Roena et al. (2015) Building Capacity to Address Women's Health Issues in the Mixtec and Zapotec Community. Womens Health Issues 25:403-9

Showing the most recent 10 out of 68 publications